BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Doddam SN, Peddireddy V, Yerra P, Sai Arun PP, Qaria MA, Baddam R, Sarker N, Ahmed N. Mycobacterium tuberculosis DosR regulon gene Rv2004c contributes to streptomycin resistance and intracellular survival. Int J Med Microbiol 2019;309:151353. [PMID: 31521502 DOI: 10.1016/j.ijmm.2019.151353] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Belardinelli JM, Verma D, Li W, Avanzi C, Wiersma CJ, Williams JT, Johnson BK, Zimmerman M, Whittel N, Angala B, Wang H, Jones V, Dartois V, de Moura VCN, Gonzalez-Juarrero M, Pearce C, Schenkel AR, Malcolm KC, Nick JA, Charman SA, Wells TNC, Podell BK, Vennerstrom JL, Ordway DJ, Abramovitch RB, Jackson M. Therapeutic efficacy of antimalarial drugs targeting DosRS signaling in Mycobacterium abscessus. Sci Transl Med 2022;14:eabj3860. [PMID: 35196022 DOI: 10.1126/scitranslmed.abj3860] [Reference Citation Analysis]
2 Yadav D, Kaur S, Banerjee D, Bhattacharyya R. Metformin and Rifampicin combination augments active to latent tuberculosis conversion: A computational study. Biotechnol Appl Biochem 2020. [PMID: 33059386 DOI: 10.1002/bab.2052] [Reference Citation Analysis]
3 Liu S, Xie Y, Luo W, Dou Y, Xiong H, Xiao Z, Zhang XL. PE_PGRS31-S100A9 Interaction Promotes Mycobacterial Survival in Macrophages Through the Regulation of NF-κB-TNF-α Signaling and Arachidonic Acid Metabolism. Front Microbiol 2020;11:845. [PMID: 32457723 DOI: 10.3389/fmicb.2020.00845] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
4 Rocha DMGC, Viveiros M, Saraiva M, Osório NS. The Neglected Contribution of Streptomycin to the Tuberculosis Drug Resistance Problem. Genes (Basel) 2021;12:2003. [PMID: 34946952 DOI: 10.3390/genes12122003] [Reference Citation Analysis]
5 Aremu OS, Qwebani-Ogunleye T, Katata-Seru L, Mkhize Z, Trant JF. Synergistic broad-spectrum antibacterial activity of Hypoxis hemerocallidea-derived silver nanoparticles and streptomycin against respiratory pathobionts. Sci Rep 2021;11:15222. [PMID: 34315915 DOI: 10.1038/s41598-021-93978-z] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
6 Heidary M, Shirani M, Moradi M, Goudarzi M, Pouriran R, Rezaeian T, Khoshnood S. Tuberculosis challenges: Resistance, co-infection, diagnosis, and treatment. Eur J Microbiol Immunol (Bp) 2022. [PMID: 35420996 DOI: 10.1556/1886.2021.00021] [Reference Citation Analysis]